NCT03364517

Brief Summary

The purpose of this study is to prospectively evaluate a standardized procedure of medical regulation based on a validated predictive score of eminent delivery (SPIA) in comparison with usual inhomogeneous practices. This standardized procedure impacting the process of care production (when receiving the call for regulation for unannounced delivery) would improve the quality of care of parturients while rationalizing the use of medical teams in the field.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,208

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

19 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 6, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

March 14, 2018

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2021

Completed
Last Updated

September 19, 2024

Status Verified

August 1, 2022

Enrollment Period

3.8 years

First QC Date

November 23, 2017

Last Update Submit

September 3, 2024

Conditions

Keywords

Medical regulationSPIAImminent delivery

Outcome Measures

Primary Outcomes (1)

  • Number of deliveries without the presence of a doctor or midwife and absence of the SMUR sent in first intention.

    It will be the number of unexpected deliveries out of medical presence.

    Through study completion, an average of eighteen months.

Secondary Outcomes (7)

  • Number of deliveries outside maternity.

    Through study completion, an average of eighteen months.

  • Number of adapted responses.

    Through study completion, an average of eighteen months.

  • Duration of the call collected on the regulation.

    At the moment of inclusion of the patient, an average one day.

  • Regulatory investigator satisfaction by a standardized questionnaire.

    Through study completion, an average of six months.

  • APGAR scores of newborn at birth and 10 minutes of delivery.

    At one minute then at ten minutes.

  • +2 more secondary outcomes

Study Arms (2)

Experimental group SPIA

EXPERIMENTAL

The regulator will be asked to systematically use the tool Predictor score of the imminence of a childbirth (SPIA). This tool is used to evaluate the means to be sent following a call for imminent delivery outside the hospital.

Other: Predictor score of the imminence of a childbirth (SPIA)

Control group

NO INTERVENTION

The classic care will be made according to the usual practices of the doctor and the center.

Interventions

The SPIA score is based on the analysis of 6 types of criteria: panic during the call, the possibility of having a telephone contact with the parturient, the urge to push and if so for how long, the rhythm of the CU, some aggravating factors (history of fast delivery or at home, maternal age between 26 and 35 years, lack of follow-up of pregnancy) and 2 minor factors (nulliparity and the taking of a tocolytic treatment). Each criteria is between 0 to 8, except for the 2 minor criteria for which 7 and 3 points are removed if they are present. This gives a score between -10 and +33, which is weighted according to the admission time estimated at the hospital (30 minutes, 1h and 2h).

Experimental group SPIA

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant woman over 33 WA
  • Age ≥ 18 years
  • Calling the regulation of SAMU-Center 15 for start of work
  • Patient not planning to give birth at home
  • Delivery not having started at the time of the first call (hair, head, buttocks or feet not visible)
  • Absence of a doctor, obstetrician or midwife on the spot during the call
  • French language included (Patient and / or Near)

You may not qualify if:

  • Opposition of the patient after sending the information note.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (19)

Centre Hospitalier René-DUBOS

Cergy-Pontoise, Cergy-pontoise, 95303, France

Location

Centre Hospitalier Universitaire d'Amiens

Amiens, 80080, France

Location

Centre Hospitalier Régional Universitaire de Besançon

Besançon, 25000, France

Location

Centre Hospitalier Universitaire Avicenne

Bobigny, 93000, France

Location

Hôpital Pellegrin

Bordeau, 33000, France

Location

Centre Hospitalier Henri Mondor

Créteil, 94010, France

Location

Centre Hospitalier Universitaire de Dijon

Dijon, 21000, France

Location

Centre Hospitalier Universitaire de Grenoble

Grenoble, 38700, France

Location

Hôpital André Mignot

Le Chesnay, 78150, France

Location

Centre Hospitalier Régional Universitaire de Lille

Lille, 59000, France

Location

Groupement Hospitalier Edouard Herriot

Lyon, 69003, France

Location

Centre Hospitalier Marc Jacquet

Melun, 77011, France

Location

Centre Hospitalier Régional Mets-Thionville

Metz, 57000, France

Location

Centre Hospitalier Annecy-Genevois

Metz-Tessy, 74370, France

Location

Centre Hospitalier Universitaire de Nancy

Nancy, 54000, France

Location

Centre Hospitalier Universitaire de Rennes

Rennes, 35033, France

Location

Centre Hospitalier Universitaire de la Réunion

Saint-Denis, 97400, France

Location

Centre Hospitalier de Toulon

Toulon, 83056, France

Location

Hôpital Purpan

Toulouse, 31059, France

Location

Study Officials

  • Agnès RICARD-HIBON

    Hôpital NOVO

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized controlled cluster study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2017

First Posted

December 6, 2017

Study Start

March 14, 2018

Primary Completion

December 14, 2021

Study Completion

December 14, 2021

Last Updated

September 19, 2024

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations